Evidence map›Paper›PMID 32502616›Full record

ArticleThe ocular surface2021

Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface.

Joseph Collin, Rachel Queen, Darin Zerti, Birthe Dorgau, Maria Georgiou, Ivo Djidrovski, Rafiqul Hussain, Jonathan M Coxhead, Agatha Joseph, Paul Rooney and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The ocular surface, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
19.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Could Ocular Glands Be Infected by SARS-CoV-2?Diseases (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Joseph CollinBiosciences Institute, Faculty of Medical Sciences, Newcastle University, UK.
Rachel QueenBiosciences Institute, Faculty of Medical Sciences, Newcastle University, UK.
Darin ZertiBiosciences Institute, Faculty of Medical Sciences, Newcastle University, UK; Microscopy Centre and Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, Italy.
Birthe DorgauBiosciences Institute, Faculty of Medical Sciences, Newcastle University, UK.
Maria GeorgiouBiosciences Institute, Faculty of Medical Sciences, Newcastle University, UK.
Ivo DjidrovskiBiosciences Institute, Faculty of Medical Sciences, Newcastle University, UK.
Rafiqul HussainBiosciences Institute, Faculty of Medical Sciences, Newcastle University, UK.
Jonathan M CoxheadBiosciences Institute, Faculty of Medical Sciences, Newcastle University, UK.
Agatha JosephNHS Blood and Transplant Tissue and Eye Services, Liverpool, UK.
Paul RooneyNHS Blood and Transplant Tissue and Eye Services, Liverpool, UK.
Steven LisgoBiosciences Institute, Faculty of Medical Sciences, Newcastle University, UK.
Francisco FigueiredoDepartment of Ophthalmology, Royal Victoria Infirmary and Newcastle University, Newcastle, UK.
Lyle ArmstrongBiosciences Institute, Faculty of Medical Sciences, Newcastle University, UK.
Majlinda LakoBiosciences Institute, Faculty of Medical Sciences, Newcastle University, UK. Electronic address: majlinda.lako@ncl.ac.uk.
Newcastle University · GBNHS Blood and Transplant · GBRoyal Victoria Infirmary · GBUniversity of L'Aquila · IT

Funding

Medical Research Council MR/R006237/1Medical Research Council MR/R011338/1Medical Research Council MR/S035826/1Wellcome Trust
6 · The paper itself

Abstract

purposeThe high infection rate of SARS-CoV-2 necessitates the need for multiple studies identifying the molecular mechanisms that facilitate the viral entry and propagation. Currently the potential extra-respiratory transmission routes of SARS-CoV-2 remain unclear.

methodsUsing single-cell RNA Seq and ATAC-Seq datasets and immunohistochemical analysis, we investigated SARS-CoV-2 tropism in the embryonic, fetal and adult human ocular surface.

resultsThe co-expression of ACE2 receptor and entry protease TMPRSS2 was detected in the human adult conjunctival, limbal and corneal epithelium, but not in the embryonic and fetal ocular surface up to 21 post conception weeks. These expression patterns were corroborated by the single cell ATAC-Seq data, which revealed a permissive chromatin in ACE2 and TMPRSS2 loci in the adult conjunctival, limbal and corneal epithelium. Co-expression of ACE2 and TMPRSS2 was strongly detected in the superficial limbal, corneal and conjunctival epithelium, implicating these as target entry cells for SARS-CoV-2 in the ocular surface. Strikingly, we also identified the key pro-inflammatory signals TNF, NFKβ and IFNG as upstream regulators of the transcriptional profile of ACE2

conclusionsTogether our data indicate that the human ocular surface epithelium provides an additional entry portal for SARS-CoV-2, which may exploit inflammatory driven upregulation of ACE2 and TMPRSS2 entry factors to enhance infection.

Indexed as

COVID-19AgedAged, 80 and overAngiotensin-Converting Enzyme 2ConjunctivaEpithelium, CornealHumansMiddle AgedReceptors, VirusSARS-CoV-2Serine EndopeptidasesACE2 protein, humanAngiotensin-Converting Enzyme 2Receptors, VirusSerine EndopeptidasesTMPRSS2 protein, humanace2ConjunctivaCorneasars-cov-2tmprss2

Identifiers

PMID32502616
PMCPMC7267807
OpenAlexW3033148310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.